Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons? (Q45051255)
Jump to navigation
Jump to search
scientific article published on 30 July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons? |
scientific article published on 30 July 2004 |
Statements
1 reference
Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons? (English)
1 reference
Centers for Disease Control and Prevention
1 reference
Richard E Chaisson
1 reference
Fred M Gordin
1 reference
David L Cohn
1 reference
John P Matts
1 reference
Richard J O'Brien
1 reference
Terry Beirn Community Programs for Clinical Research on AIDS
1 reference
Adult AIDS Clinical Trials Group
1 reference
30 July 2004
1 reference
1 reference
Identifiers
1 reference